Sectors > > Rexahn Pharmaceuticals Inc

Rexahn Pharmaceuticals Inc(NYSE_MKT:RNN)

Market Overview

0.48

0.02(3.26%)
Vol 2,856,025
10 Days Avg Vol 895400
3 Mo Avg Vol 95970600
52 Wk Lo/Hi $0.65 - $1.04
YTD Price Gain % 5.7%
10 Wks Moving Avg 0.72
200 Days Moving Avg 0.74
Liquidity Ratio 237.2
Market Cap 117,819,606

Summary

Rexahn Pharmaceuticals, Inc., is a development stage biopharmaceutical company engaged in the development of novel treatments for cancer to patients.

Contact Information


Rexahn Pharmaceuticals Inc

Suite 455
15245 Shady Grove Road

Rockville MD 20850

+1 240 268-530

+1 240 268-531

ir@rexahn.com

http://www.rexahn.com

Peter D. Suzdak,PhD